Introduction
MIBG SPECT-CT (Metaiodobenzylguanidine Single Photon Emission Computed Tomography – Computed Tomography) is a specialized nuclear medicine imaging technique used to evaluate tumors arising from neural crest tissue.
It is particularly valuable for detecting and localizing certain neuroendocrine and adrenal tumors that actively uptake MIBG.
MIBG is structurally similar to norepinephrine and is taken up by adrenergic tissue, allowing functional visualization of tumors such as pheochromocytomas, paragangliomas, and selected neuroblastomas.
When combined with CT imaging, MIBG SPECT-CT provides precise anatomical localization to support diagnosis and treatment planning.
Türkiye is a trusted destination for advanced neuroendocrine imaging, offering modern SPECT-CT technology, experienced nuclear medicine specialists, and integrated endocrine and oncology care.
Averia Health supports international patients through ethical, structured, and fully coordinated MIBG SPECT-CT services focused on diagnostic accuracy and clinical clarity.
Why Choose Türkiye for MIBG SPECT-CT
Türkiye is internationally recognized for high-quality neuroendocrine imaging because of:
- Advanced SPECT-CT scanners optimized for functional tumor imaging
- Availability of MIBG radiotracers
- Experienced nuclear medicine physicians with neuroendocrine expertise
- Strict radiation safety and quality assurance protocols
- Multidisciplinary collaboration with endocrinology, oncology, and surgery teams
- Internationally accredited hospitals and diagnostic centers
Türkiye combines advanced imaging technology with expert clinical interpretation.
Why Choose Averia Health
Averia Health provides comprehensive coordination for MIBG SPECT-CT imaging:
- Pre-arrival review of medical history, laboratory results, and prior imaging
- Referral to accredited nuclear medicine centers
- Clear explanation of the procedure, preparation, and medication requirements
- Coordination with endocrinologists, oncologists, and surgeons
- Professional interpreter services
- 24/7 patient support during your visit
- Timely reporting and international follow-up coordination
Our approach prioritizes transparency, precision, and patient reassurance.
Conditions Evaluated with MIBG SPECT-CT
MIBG SPECT-CT is commonly used to evaluate:
- Pheochromocytoma
- Paraganglioma
- Neuroblastoma (selected cases)
- Adrenal medullary tumors
- Metastatic neuroendocrine tumors with adrenergic uptake
- Disease staging and recurrence assessment
The scan is recommended based on biochemical findings and specialist assessment.
Role of MIBG SPECT-CT in Neuroendocrine Tumors
Tumor Localization
Identifies MIBG-avid tumors with high specificity.
Disease Staging
Assesses spread to lymph nodes or distant organs.
Treatment Planning
Supports surgical planning or targeted radionuclide therapy decisions.
Follow-Up and Monitoring
Evaluates response to treatment or detects recurrence.
Results are interpreted alongside biochemical tests and clinical findings.
Diagnostic Evaluation Before MIBG SPECT-CT
Preparation and evaluation may include:
- Review of hormone and catecholamine laboratory results
- Review of prior imaging (CT, MRI, PET scans)
- Medication review, including drugs that may interfere with MIBG uptake
- Thyroid blockade medication before tracer administration
- Assessment for pregnancy or breastfeeding when applicable
Proper preparation is essential for accurate imaging and safety.
MIBG SPECT-CT Scan Journey in Türkiye
- Pre-Arrival Case Review
Medical records, laboratory data, and imaging indications are reviewed in advance. - Nuclear Medicine Consultation
The procedure, tracer mechanism, and preparation steps are explained clearly. - MIBG Tracer Administration
A small, medically safe amount of MIBG radiotracer is administered intravenously. - SPECT-CT Imaging
Functional and anatomical imaging is performed at scheduled intervals. - Image Interpretation
Scans are analyzed by experienced nuclear medicine specialists. - Results & Care Coordination
Findings are shared with your treating physician to guide management.
Expected Results & Benefits
- Accurate localization of MIBG-avid tumors
- Improved diagnostic confidence in neuroendocrine disease
- Support for precise surgical or medical treatment planning
- Detection of metastatic or recurrent disease
- Reduced diagnostic uncertainty in complex cases
MIBG SPECT-CT remains a key imaging modality for selected neuroendocrine tumors.
Risks & Considerations
MIBG SPECT-CT is safe and well established. Considerations include:
- Exposure to a controlled, low level of radiation
- Temporary discomfort from tracer injection
- Need for thyroid protection medication
- Medication adjustments prior to the scan
- Results must be interpreted in clinical context
Radiation exposure is minimized and justified by diagnostic benefit.
What’s Included in Your Medical Visit
- MIBG SPECT-CT scan appointment
- Nuclear medicine consultation
- Thyroid blockade medication
- MIBG radiotracer administration
- SPECT-CT imaging and expert interpretation
- Written diagnostic report
- Coordination with endocrinology or oncology teams
- Interpreter services
- Patient support and follow-up coordination
Averia Health ensures ethical, precise, and patient-centered neuroendocrine imaging care.
Frequently Asked Questions
What tumors are best evaluated with MIBG SPECT-CT?
Pheochromocytomas, paragangliomas, and selected neuroendocrine tumors.
Is MIBG SPECT-CT better than PET-CT?
It is more specific for MIBG-avid tumors; choice depends on tumor biology.
Is thyroid protection necessary?
Yes. Thyroid blockade is used to prevent iodine uptake by the thyroid.
Is the scan safe?
Yes. It is performed under strict safety protocols.
How quickly will results be available?
Results are typically available shortly after expert interpretation.
Ready to Start Your Health Journey?
Access precise neuroendocrine tumor imaging with advanced MIBG SPECT-CT in Türkiye.
Request a free case review or contact us on WhatsApp to speak with our diagnostic care coordination team.
